APP and Alzheimer disease: Naturally, the most important criteria for the translational value of SWDs in AD mouse models to will be their predictive validity, i.e. whether drugs suppressing SWDs in APP transgenic mice will also suppress nonconvulsive spiking in MCI/AD patients.